Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To understand the severity and potential impact of heterogeneity in definitions of hypoglycemia used in diabetes research, we aimed to review the hypoglycemia definitions adopted in randomized controlled trials (RCTs). METHODS: We reviewed 109 RCTs included in the Canadian Agency for Drugs and Technologies in Health reports for the second- and third-line therapy for the patients with type 2 diabetes (T2D). RESULTS: Nearly 60% (n=66) of the studies reviewed presented the definitions for overall hypoglycemia, and another 20% (n=22) of the studies reported the results for hypoglycemia but did not report a definition. Among these 66 studies, only 9 (14%) followed the American Diabetes Association/European Medicines Agency specified guidelines to define hypoglycemia, with an exact threshold of plasma glucose ≤3.9 mmol/L. Fifty-two of the 66 studies (79%) used a threshold considerably lower than the recommended ≤3.9 mmol/L, and 16 studies used a threshold between 3.8 and 4.0 mmol/L. The proportion of the trials that used a cutoff value of <3.1 mmol/L appeared to be slightly similar among the more commonly used non-insulin treatments, GLP-1s (7 of 18 [39%]), thiazolidinediones (TZDs; 6 of 11 [55%]), DPP-4s (12 of 19 [64%]), and sulfonylureas (11 of 20 [55%]). Among trials with intermediate-long-acting insulins (neutral protamine Hagedorn insulin, detemir, glargine), 7 of 26 trials (27%) used a cutoff of <3.1 mmol/L. The definition of severe hypoglycemia was also subject to substantial heterogeneity, in both the utilized threshold and accompanying soft definitions. CONCLUSION: This review demonstrates that substantial heterogeneity exists in the definition of overall, severe/major, and nocturnal hypoglycemia across RCTs investigating T2D interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The definition of hypoglycemia has varied over the years and amongst worldwide expert opinion [2].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1092 · Cited by 1,559 · cited 1×
“As such, where no 15 Subjects required the assistance of another person to obtain treatment for their hypoglycemia, including intravenous glucose or intramuscular glucagon Marre et al 16 Severe hypoglycemia (grade 3 or 4 on a scale of 1–4, on which a score of 1 was given for symptoms that did not…”
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825 · cited 1×
“symptoms, which in turn can lead to death, if not treated on time.(3) Therefore, addressing the issue of hypoglycemia is a very important aspect in both diabetic care and research.”
BackgroundHeine, R. J., Van Gaal, L. F., Johns, D., Mihm, M. J., Widel, M. H., Brodows, R. G., & for the GWAA Study Group* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-8-200510180-00006 · Cited by 795
Bergenstal, R. M., Wysham, C., MacConell, L., Malloy, J., Walsh, B., Yan, P., Wilhelm, K., Malone, J., & Porter, L. E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60590-9 · Cited by 608
Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications
Frier, B. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.170 · Cited by 481
Hypoglycemia in Type 2 Diabetes
Zammitt, N. N., & Frier, B. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2948 · Cited by 435
Insulin glargine or NPH combined with metformin in type 2 diabetes: The LANMET study
Yki-Järvinen, H., Kauppinen-Mäkelin, R., Tiikkainen, M., Vähätalo, M., Virtamo, H., Nikkilä, K., Tulokas, T., Hulme, S., Hardy, K., McNulty, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0132-0 · Cited by 434
Cited by
Rojas-Gutierrez, E., Muñoz-Arenas, G., Treviño, S., Espinosa, B., Chavez, R., Rojas, K., Flores, G., Díaz, A., & Guevara, J. (2017) · Synapse · doi:10.1002/syn.21990 · Cited by 192
Fear of hypoglycemia---an underestimated problem
Przezak, A., Bielka, W., & Molęda, P. (2022) · Brain and Behavior · doi:10.1002/brb3.2633 · Cited by 110
A comparison of isomaltulose versus maltodextrin ingestion during soccer-specific exercise
Stevenson, E. J., Watson, A., Theis, S., Holz, A., Harper, L. D., & Russell, M. (2017) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3719-5 · Cited by 48
König, A., Schwarzinger, B., Stadlbauer, V., Lanzerstorfer, P., Iken, M., Schwarzinger, C., Kolb, P., Schwarzinger, S., Mörwald, K., Brunner, S. M., et al. (2019) · Nutrients · doi:10.3390/nu11071512 · Cited by 55
Bedry, T., & Tadele, H. (2020) · Emergency Medicine International · doi:10.1155/2020/1965231 · Cited by 53
Demlie, T. A., Alemu, M. T., Messelu, M. A., Wagnew, F., & Mekonen, E. G. (2023) · BMC Emergency Medicine · doi:10.1186/s12873-023-00823-9 · Cited by 39
Mattishent, K., & Loke, Y. K. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.005 · Cited by 38
Alterations of circular RNAs in hyperglycemic human endothelial cells
Shang, F., Luo, S., Liang, X., & Xia, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.187 · Cited by 35
Muneer, M. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2020_534 · Cited by 28
Pediatric-Onset Postural Orthostatic Tachycardia Syndrome in a Single Tertiary Care Center
Staples, A., Thompson, N. R., & Moodley, M. (2020) · Journal of Child Neurology · doi:10.1177/0883073820916260 · Cited by 26
Farngren, J., & Åhrén, B. (2019) · Metabolism · doi:10.1016/j.metabol.2019.06.016 · Cited by 21
Li, S., Li, Y., Zhang, L., Bi, Y., Zou, Y., Liu, L., Zhang, H., Yuanyuan, Gong, W., & Zhang, Y. (2022) · Acta Diabetologica · doi:10.1007/s00592-021-01839-y · Cited by 21
Ghasemi, H., Sabati, Z., Ghaedi, H., Salehi, Z., & Alipoor, B. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04937-x · Cited by 17
Kumar, S. (2021) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_276_21 · Cited by 23
Yin, X., Zhu, W., Liu, C., Yao, H., You, J., Chen, Y., Ying, X., & Li, L. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221099337 · Cited by 15
Li, X., Kan, Y., Liu, H.-Y., Pang, J., He, Y., Liu, L., Zou, Y., Zhang, N., & Zhang, Y. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02102-2 · Cited by 17
DIY artificial pancreas: A narrative of the first patient and the physicians’ experiences from India
Kesavadev, J., Saboo, B., Kar, P. S., & Sethi, J. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.02.033 · Cited by 18
Reporting of hypoglycaemia in clinical trials of basal insulins: A need for consensus
Frier, B. M., Ratzki‐Leewing, A. A., & Harris, S. B. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13732 · Cited by 12
Bienvenot, R., Sirveaux, M., Nguyen‐Thi, P., Brunaud, L., & Quilliot, D. (2021) · Obesity · doi:10.1002/oby.23118 · Cited by 15
Alvarez, S. D., Fellas, A., Santos, D., Sculley, D., Wynne, K., Acharya, S., Navathe, P. D., Gironès, X., & Coda, A. (2023) · JMIR Diabetes · doi:10.2196/42389 · Cited by 11
Bosch, R., Petrone, M., Arends, R., Vicini, P., Sijbrands, E. J. G., Hoefman, S., & Snelder, N. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16336 · Cited by 11
Alkabbani, W., Maxwell, C. J., Marrie, R. A., Tyas, S. L., Lega, I. C., & Gamble, J. (2022) · International Journal of Epidemiology · doi:10.1093/ije/dyac168 · Cited by 12
Saiman, Y., & Mahmud, N. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002218 · Cited by 9
Dose-related hypoglycemia in venlafaxine poisoning: a retrospective cohort study
Bekka, E., & Eyer, F. (2022) · Clinical Toxicology · doi:10.1080/15563650.2022.2138762 · Cited by 10
Savoury cracker development for blood glucose control and management
Qi, X., Ta, M. N., & Tester, R. F. (2020) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2020.100249 · Cited by 8
Holt, R. I. G., Dritsakis, G., Barnard-Kelly, K. D., Thorne, K. I., Whitehead, A. L., Cohen, L., Dixon, E. L., Patel, M. A., Newland‐Jones, P., Green, M., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050919 · Cited by 8
Kamalinia, S., Josse, R. G., Donio, P. J., Leduc, L., Shah, B. R., & Tobe, S. W. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.100 · Cited by 7
Atbaşoğlu, C., Akay, G. G., Gülöksüz, S., Saka, M. C., Üçok, A., Alptekın, K., Güllü, S., & van Os, J. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4818-z · Cited by 7
Almomani, H. Y., Pascual, C., Al-Azzam, S. I., & Ahmadi, K. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.07.012 · Cited by 7
Urbanová, J., Brunerová, L., & Brož, J. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107914 · Cited by 7
Energy expenditure and glucose-lowering effect of different exercise modalities in diabetes mellitus
Bozdemir-Özel, C., Arıkan, H., Kutukcu, E. C., Karadüz, B. N., Inal-Ince, D., Kabakçı, G., & Dağdelen, S. (2022) · Physiotherapy · doi:10.1016/j.physio.2022.08.009 · Cited by 5
Ji, L., Gao, Z., Shi, B., Bian, R., Yin, F., Pang, W., Gao, H., & Cui, N. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0717-x · Cited by 5
Setford, S. J., Phillips, S., & Grady, M. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819826968 · Cited by 5
Rodríguez‐Gutiérrez, R., Salcido‐Montenegro, A., González‐González, J. G., & McCoy, R. G. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001906 · Cited by 5
D’Souza, N. C., Aiken, J., Hoffman, E. G., ATHERLEY, S. C., Champsi, S., ALEALI, N., Shakeri, D., El-Zahed, M., Akbarian, N., Nejad-Mansouri, M., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1302015 · Cited by 8
Recomendaciones para la práctica clínica: hipoglucemia en personas con diabetes mellitus
Martín, C. G., Loredo, S. D., Forlino, M., Rodríguez, A., Ré, M., Santos, N. C. G., Dimov, L., Apoloni, S. B., Remón, J., Ávila, P. J., et al. (2022) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v56i2sup.539 · Cited by 3
Análisis retrospectivo de las hipoglucemias inducidas por venlafaxina en pacientes con sobredosis
Gomila, I., Crespí, L. S., Ferrando, J. P., Marti, A. M. G., Guerrero, M. Á. E., & Martín, B. B. (2024) · Medicina Clínica · doi:10.1016/j.medcli.2023.11.002 · Cited by 2
Saidi, A. A., Shamsi, M. A., Farsi, A. A., & Tubi, S. A. (2025) · Cureus · doi:10.7759/cureus.80375 · Cited by 4
Isnani, S.-L. J., Macalalad-Josue, A. A., & Jimeno, C. (2021) · Acta Medica Philippina · doi:10.47895/amp.v55i1.2926 · Cited by 4
Ibrahim, I., Macatangay, R., Chai, C. Y., Khoo, C. M., & Mahadevan, M. (2021) · BMC Emergency Medicine · doi:10.1186/s12873-021-00460-0 · Cited by 1
Prince, N., Lochnan, H., Shorr, R., Garon-Mailer, A., & Sun, C. J. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02144-3
“The definition of hypoglycemia has varied over the years and amongst worldwide expert opinion [2].”
Risk Indicators of Non-severe Hypoglycemia in Type 2 Diabetes: An Analysis of Real World Data
Au, N. H. (2018) · Scholarship@Western (Western University)
MBBS, M. G. M., & Sekhar, D. M. S. (2020) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v8i11.30
Clinical, metabolic and hormonal features of the formation of impaired hypoglycemia awareness
Reva, I. А., & Bondar', I. A. (2021) · JOURNAL of SIBERIAN MEDICAL SCIENCES · doi:10.31549/2542-1174-2021-4-97-107
Dasiglucagon for treating severe hypoglycemia in patients with diabetes
Ju, Y., Zhang, D., & Yang, J. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2103537
Clinical Evaluation of Predisposing Factors of Hypoglycaemia in Diabetic Patients
Rahman, M. M., Talukder, S., Baker, I. M., Das, A., Baset, M. A., & Najnin, F. (2023) · TAJ Journal of Teachers Association · doi:10.3329/taj.v35i2.63763
Hypoglycemia with Beta-Blocker in Patients with Type II Diabetes
Wali, R., Muhammad, N., Rahman, N. A., Khan, T. U., Waqas, M. S., & Khan, M. U. (2023) · Life and Science · doi:10.37185/lns.1.1.340
Estrategias para mitigar hipoglucemias y variabilidad glucémica
Carnero, R., Saleme, A., Lequi, L., Daín, A., Rubín, G., Campos, F. S., Sosa, L., Flores, A., & Kabakian, L. (2022) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v56i2sup.533 · Cited by 1
Retrospective analysis of venlafaxine-induced hypoglycemia in patients with overdose
Gomila, I., Crespí, L. S., Ferrando, J. P., Marti, A. M. G., Guerrero, M. Á. E., & Martín, B. B. (2024) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2023.11.006
Nurhayati, P., Irham, A. M., Pramana, I. D. B. K. W., & Harahap, H. S. (2022) · Unram Medical Journal · doi:10.29303/jk.v11i1.4342 · Cited by 5
Thorlund, K., Park, J., Wise, M. P., Doleman, B., Petersen, J., Lange, T., Mathiesen, O., Skrifvars, M., Saxena, M., Nielsen, N., et al. (2026) · Clinical Epidemiology · doi:10.2147/clep.s580997
Self-citationKhutornoy, I. V., Sivitskaya, N., Alshevskaya, A., Fatkhullin, M., & Aksenova, E. I. (2026) · Information · doi:10.3390/info17080776
Metadata
- Authors
- Balijepalli, C., Druyts, E., Siliman, G., Joffres, M., Thorlund, K., & Mills, E.
- Affiliations
- Simon Fraser University (CA)
- McMaster University (CA)
- Corresponding author
- Balijepalli, Chakrapani
- Venue
- Clinical Epidemiology
- Publisher
- Informa UK Limited
- Published
- 2017-05
- Volume
- Volume 9
- Pages
- 291-296
- ISSN
- 1179-1349 (ISSN-L)
- PMC
- PMC5448700
- OpenAlex
- W2617275116
- Cited by
- 52
- References
- 28
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 5 · 2022: 10 · 2021: 9 · 2020: 6 · 2019: 7 · 2018: 5 · 2017: 2
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical Epidemiology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, hypoglycemia definition, type 2 diabetes, antidiabetic drugs, hypoglycemia severity, severe hypoglycemia, nocturnal hypoglycemia, GLP-1 receptor agonists, thiazolidinediones, DPP-4 inhibitors, sulfonylureas, long-acting insulin, clinical trial heterogeneity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

